PNKD
Probable thioesterase PNKD
Also known as: BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, PNKD_HUMAN, TAHCCP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N490
- Gene
- PNKD
- Ensembl
- ENSG00000127838
- Chromosome
- 2
- Canonical length
- 385 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
385 residues, UniProt reviewed canonical sequence.
>Q8N490|PNKD
1 MAAVVAATAL KGRGARNARV LRGILAGATA NKASHNRTRA LQSHSSPEGK EEPEPLSPEL
61 EYIPRKRGKN PMKAVGLAWY SLYTRTWLGY LFYRQQLRRA RNRYPKGHSK TQPRLFNGVK
121 VLPIPVLSDN YSYLIIDTQA QLAVAVDPSD PRAVQASIEK EGVTLVAILC THKHWDHSGG
181 NRDLSRRHRD CRVYGSPQDG IPYLTHPLCH QDVVSVGRLQ IRALATPGHT QGHLVYLLDG
241 EPYKGPSCLF SGDLLFLSGC GRTFEGNAET MLSSLDTVLG LGDDTLLWPG HEYAEENLGF
301 AGVVEPENLA RERKMQWVQR QRLERKGTCP STLGEERSYN PFLRTHCLAL QEALGPGPGP
361 TGDDDYSRAQ LLEELRRLKD MHKSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PNKD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 190 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 190 nTPM
- basal ganglia: 109 nTPM
- kidney: 106 nTPM
- cerebral cortex: 105 nTPM
- midbrain: 101 nTPM
- liver: 100 nTPM
Single-cell type
- parietal cells: 361 nCPM
- epicardial cells: 316 nCPM
- colonocytes: 310 nCPM
- epididymal principal cells: 306 nCPM
- hepatocytes: 282 nCPM
- decidual stromal cells: 258 nCPM
Immune cell
- memory B-cell: 224 nTPM
- naive B-cell: 188 nTPM
- eosinophil: 152 nTPM
- T-reg: 150 nTPM
- basophil: 143 nTPM
- NK-cell: 136 nTPM
Brain region
- cerebral cortex: 112 nTPM
- hypothalamus: 87 nTPM
- thalamus: 85 nTPM
- basal ganglia: 77 nTPM
- pons: 75 nTPM
- cerebellum: 75 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PNKD.
Disease | AllUniProt
Conditions PNKD is implicated in, by any mechanism.
- Paroxysmal non-kinesigenic dyskinesia 1 (PNKD1) MIM:118800
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 681 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Paroxysmal nonkinesigenic dyskinesia 1
- Paroxysmal nonkinesigenic dyskinesia
- Episodic hemiplegia
- Paroxysmal dyskinesia
- Paroxysmal dystonia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione
- negative regulation of neurotransmitter secretion
- neuromuscular process controlling posture
- regulation of dopamine metabolic process
- regulation of synaptic transmission, dopaminergic
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PNKD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PNKD as an antibody target. Whether an autoantibody or antibody against PNKD could matter depends on whether native PNKD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PNKD is annotated at the cell surface, where native PNKD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PNKD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...